Development of a Novel Fluorescent-Based Lateral Flow Assay for the Detection of Neisseria gonorrhoeae at the Point of Care.

Journal: Sexually transmitted diseases
PMID: 38412465

Abstract

BACKGROUND: Neisseria gonorrhoeae (NG) has acquired significant resistance, primarily due to extensive and unwarranted antibiotic utilization over several decades. This resistance has largely been associated with the syndromic management of sexually transmitted infections, particularly in low- and middle-income countries where affordable point of care tests are unavailable. To address this diagnostic gap, FIND has developed a low-cost lateral flow assay for the detection of NG at the point of care.

Authors

  • Birgitta Gleeson
    From the FIND, Geneva, Switzerland.
  • Jeremie Piton
    From the FIND, Geneva, Switzerland.
  • Laura Mazzola
    From the FIND, Geneva, Switzerland.
  • Sean McHugh
    DCN Dx, Carlsbad, CA.
  • Jillian Bender
    DCN Dx, Carlsbad, CA.
  • Madison Lear
    DCN Dx, Carlsbad, CA.
  • Tatyana Gavrikova
    UAB Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL.
  • Barbara Van Der Pol
    UAB Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL.
  • Brice Daniels
    UAB Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL.
  • Jennifer Osborn
    From the FIND, Geneva, Switzerland.
  • Peter Dailey
    From the FIND, Geneva, Switzerland.
  • Cecilia Ferreyra
    From the FIND, Geneva, Switzerland.

Keywords

External Resources

Popular Topics
Recent Journals